260 related articles for article (PubMed ID: 11376528)
1. Microthrombosis in sepsis.
Vallet B
Minerva Anestesiol; 2001 Apr; 67(4):298-301. PubMed ID: 11376528
[TBL] [Abstract][Full Text] [Related]
2. Anticoagulant factor concentrates in disseminated intravascular coagulation: rationale for use and clinical experience.
de Jonge E; van der Poll T; Kesecioglu J; Levi M
Semin Thromb Hemost; 2001 Dec; 27(6):667-74. PubMed ID: 11740690
[TBL] [Abstract][Full Text] [Related]
3. [Anticoagulant and fibrinolytic systems of the injured vascular endothelial cells].
Takeya H; Suzuki K
Rinsho Byori; 1994 Apr; 42(4):333-9. PubMed ID: 8176840
[TBL] [Abstract][Full Text] [Related]
4. [Endothelial cells and coagulation abnormalities].
Uchiba M; Okajima K
Rinsho Byori; 2000 Apr; 48(4):308-13. PubMed ID: 10810875
[TBL] [Abstract][Full Text] [Related]
5. Anticoagulant therapy in acute lung injury.
Laterre PF; Wittebole X; Dhainaut JF
Crit Care Med; 2003 Apr; 31(4 Suppl):S329-36. PubMed ID: 12682461
[TBL] [Abstract][Full Text] [Related]
6. A physiologic anti-inflammatory pathway based on thrombomodulin expression and generation of activated protein C by human mononuclear phagocytes.
Grey ST; Hancock WW
J Immunol; 1996 Mar; 156(6):2256-63. PubMed ID: 8690916
[TBL] [Abstract][Full Text] [Related]
7. [Coagulation tests in septic surgical patients].
Oberhofer D; Kucisec-Tepes N; Skok J; Vucić N; Cala K
Acta Med Croatica; 2004; 58(5):389-94. PubMed ID: 15756805
[TBL] [Abstract][Full Text] [Related]
8. Pathogenesis and treatment of disseminated intravascular coagulation in the septic patient.
Levi M
J Crit Care; 2001 Dec; 16(4):167-77. PubMed ID: 11815902
[TBL] [Abstract][Full Text] [Related]
9. [Protein C and coagulation in sepsis].
D'Angelo A; Della Valle P; Giudici D; Viganò D'Angelo S
Minerva Anestesiol; 2004 May; 70(5):339-50. PubMed ID: 15181414
[TBL] [Abstract][Full Text] [Related]
10. Role of coagulation inhibitors in inflammation.
Esmon CT
Thromb Haemost; 2001 Jul; 86(1):51-6. PubMed ID: 11487041
[TBL] [Abstract][Full Text] [Related]
11. [[Antithrombin III concentrates in the treatmetn of sepsis and septic shock: indictions, limits and future prospects] ].
Baudo F; de Cataldo F
Minerva Anestesiol; 2000 Nov; 66(11 Suppl 1):3-23. PubMed ID: 11213542
[TBL] [Abstract][Full Text] [Related]
12. Coagulopathy after successful cardiopulmonary resuscitation following cardiac arrest: implication of the protein C anticoagulant pathway.
Adrie C; Monchi M; Laurent I; Um S; Yan SB; Thuong M; Cariou A; Charpentier J; Dhainaut JF
J Am Coll Cardiol; 2005 Jul; 46(1):21-8. PubMed ID: 15992630
[TBL] [Abstract][Full Text] [Related]
13. Thrombin downregulates thrombomodulin expression and activity in primary human endothelial cells.
Séguin C; Abid MR; Spokes KC; Aird WC
Endothelium; 2008; 15(3):143-8. PubMed ID: 18568955
[TBL] [Abstract][Full Text] [Related]
14. Studies on the inflammatory-coagulant axis in the baboon response to E. coli: regulatory roles of proteins C, S, C4bBP and of inhibitors of tissue factor.
Taylor FB
Prog Clin Biol Res; 1994; 388():175-94. PubMed ID: 7831358
[TBL] [Abstract][Full Text] [Related]
15. Thrombomodulin: a linker of coagulation and fibrinolysis and predictor of risk of arterial thrombosis.
Wu KK; Matijevic-Aleksic N
Ann Med; 2000 Dec; 32 Suppl 1():73-7. PubMed ID: 11209986
[TBL] [Abstract][Full Text] [Related]
16. [Antithrombin: prospects in clinical practice. Sespsi: anticoagulant or anti-inflammatory agents?].
Imberti D
Minerva Anestesiol; 2003 May; 69(5):371-5. PubMed ID: 12768169
[TBL] [Abstract][Full Text] [Related]
17. Activation of the fibrinolytic system and utilization of the coagulation inhibitors in sepsis: comparison with severe sepsis and septic shock.
Mavrommatis AC; Theodoridis T; Economou M; Kotanidou A; El Ali M; Christopoulou-Kokkinou V; Zakynthinos SG
Intensive Care Med; 2001 Dec; 27(12):1853-9. PubMed ID: 11797019
[TBL] [Abstract][Full Text] [Related]
18. Amplified anticoagulant activity of tissue factor-targeted thrombomodulin: in-vivo validation of a tissue factor-neutralizing antibody fused to soluble thrombomodulin.
Wang YX; Wu C; Vincelette J; Martin-McNulty B; Alexander S; Larsen B; Light DR; McLean K
Thromb Haemost; 2006 Sep; 96(3):317-24. PubMed ID: 16953273
[TBL] [Abstract][Full Text] [Related]
19. Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock.
Creasey AA; Chang AC; Feigen L; Wün TC; Taylor FB; Hinshaw LB
J Clin Invest; 1993 Jun; 91(6):2850-60. PubMed ID: 8514893
[TBL] [Abstract][Full Text] [Related]
20. Inflammation and the activated protein C anticoagulant pathway.
Esmon CT
Semin Thromb Hemost; 2006 Apr; 32 Suppl 1():49-60. PubMed ID: 16673266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
